EP1581551A4 - Antagonistes du récepteur de f11 (f11r) en tant qu'agents thérapeutiques - Google Patents

Antagonistes du récepteur de f11 (f11r) en tant qu'agents thérapeutiques

Info

Publication number
EP1581551A4
EP1581551A4 EP03815213A EP03815213A EP1581551A4 EP 1581551 A4 EP1581551 A4 EP 1581551A4 EP 03815213 A EP03815213 A EP 03815213A EP 03815213 A EP03815213 A EP 03815213A EP 1581551 A4 EP1581551 A4 EP 1581551A4
Authority
EP
European Patent Office
Prior art keywords
antagonists
receptor
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03815213A
Other languages
German (de)
English (en)
Other versions
EP1581551A2 (fr
Inventor
Elizabeth Kornecki
Anna Babinska
Yigal H Ehrlich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1581551A2 publication Critical patent/EP1581551A2/fr
Publication of EP1581551A4 publication Critical patent/EP1581551A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP03815213A 2003-01-03 2003-12-16 Antagonistes du récepteur de f11 (f11r) en tant qu'agents thérapeutiques Withdrawn EP1581551A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43866903P 2003-01-03 2003-01-03
US438669P 2003-01-03
PCT/US2003/039890 WO2004063327A2 (fr) 2003-01-03 2003-12-16 Antagonistes du recepteur de f11 (f11r) en tant qu'agents therapeutiques

Publications (2)

Publication Number Publication Date
EP1581551A2 EP1581551A2 (fr) 2005-10-05
EP1581551A4 true EP1581551A4 (fr) 2007-12-12

Family

ID=32713364

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03815213A Withdrawn EP1581551A4 (fr) 2003-01-03 2003-12-16 Antagonistes du récepteur de f11 (f11r) en tant qu'agents thérapeutiques

Country Status (5)

Country Link
EP (1) EP1581551A4 (fr)
JP (1) JP2006516255A (fr)
AU (1) AU2003297124A1 (fr)
CA (1) CA2512399A1 (fr)
WO (1) WO2004063327A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050265992A1 (en) 2003-01-03 2005-12-01 The Research Foundation Of State University Of New York F11 receptor (F11R) antagonists as therapeutic agents
US8557957B2 (en) 2003-01-03 2013-10-15 Elizabeth Kornecki Methods of treating disorders by administration of F11 receptor antagonists
WO2020256795A1 (fr) * 2019-06-19 2020-12-24 The Research Foundation For The State University Of New York Procédés de traitement de l'hyperplasie néointimale au moyen d'inhibiteurs de f11r/jam-a

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665701A (en) * 1994-11-17 1997-09-09 The Research Foundation Of State University Of New York Platelet membrane glycoprotein F11 and polypeptide fragments thereof
WO1999002561A1 (fr) * 1997-07-10 1999-01-21 Smithkline Beecham Corporation Antigene f11 humain, constituant un recepteur de surface cellulaire implique dans l'agregation plaquettaire

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699688B1 (en) * 1998-09-16 2004-03-02 The Research Foundation Of The State University Of New York Human platelet F11 receptor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665701A (en) * 1994-11-17 1997-09-09 The Research Foundation Of State University Of New York Platelet membrane glycoprotein F11 and polypeptide fragments thereof
WO1999002561A1 (fr) * 1997-07-10 1999-01-21 Smithkline Beecham Corporation Antigene f11 humain, constituant un recepteur de surface cellulaire implique dans l'agregation plaquettaire

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BABINSKA ANNA ET AL: "Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion", THROMBOSIS AND HAEMOSTASIS, vol. 87, no. 4, April 2002 (2002-04-01), pages 712 - 721, XP002456220, ISSN: 0340-6245 *
SOBOCKA MALGORZATA B ET AL: "Cloning of the human platelet F11 receptor: A cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation", BLOOD, vol. 95, no. 8, 15 April 2000 (2000-04-15), pages 2600 - 2609, XP002456219, ISSN: 0006-4971 *

Also Published As

Publication number Publication date
EP1581551A2 (fr) 2005-10-05
WO2004063327A3 (fr) 2005-04-21
AU2003297124A1 (en) 2004-08-10
WO2004063327A2 (fr) 2004-07-29
CA2512399A1 (fr) 2004-07-29
AU2003297124A8 (en) 2004-08-10
JP2006516255A (ja) 2006-06-29

Similar Documents

Publication Publication Date Title
GB0303910D0 (en) Therapeutic agents
GB0308318D0 (en) Therapeutic agents
GB0314079D0 (en) Therapeutic agents
GB0314057D0 (en) Therapeutic agents
IL173746A0 (en) Modified il-4 mutein receptor antagonists
GB0313250D0 (en) Therapeutic agents
GB0314049D0 (en) Therapeutic agents
GB0314129D0 (en) Therapeutic agents
AU2003267088A8 (en) Chemokine receptor antagonists as therapeutic agents
GB0311859D0 (en) Therapeutic agents
GB0311201D0 (en) Therapeutic agents
GB0301350D0 (en) Therapeutic agents
IL173337A0 (en) Receptor
AU2003297124A8 (en) F11 receptor(f11r) antagonists as therapeutic agents
EP1915388A4 (fr) Utilisation d'antagonistes du recepteur f11 receptor (f11r) comme agents therapeutiques
GB0304524D0 (en) Therapeutic agents
GB0314075D0 (en) Therapeutic agents
GB0314131D0 (en) Therapeutic agents
GB0314078D0 (en) Therapeutic agents
GB0321998D0 (en) Receptor
GB0315252D0 (en) Receptor proteins
GB0220459D0 (en) Receptor proteins
GB0223877D0 (en) Receptor proteins
GB0307100D0 (en) Receptor
GB0329104D0 (en) Receptor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050704

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20071108

17Q First examination report despatched

Effective date: 20090302

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110927